EORTC 10968: A Phase I Clinical And Pharmacokinetic Study Of Polyethylene Glycol Liposomal Doxorubicin (Caelyx®, Doxil®) At A 6-week Interval In Patients With Metastatic Breast Cancer
A. Hamilton, L. Biganzoli, R. Coleman, L. Mauriac, P. Hennebert, A. Awada, M. Nooij, L. Beex, M. Piccart, I. Van Hoorebeeck, P. Bruning, D. de Valeriola
Twitter
Facebook
LinkedIn
Email